Upsher-Smith Laboratories
Manufacturing · Minnesota, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
6701 Evenstad Dr N, Maple Grove, Minneso...Phone Number
(800) 654-2299Website
www.upsher-smith.comRevenue
$274.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
4
1
1
1
1
About Upsher-Smith Laboratories
Founded in 1919, Upsher-Smith Laboratories, LLC is an American pharmaceutical company that specializes in a wide variety of generics, as well as several brand medications that help patients living with seizure disorders and migraine headaches. Upsher-Smith Laboratories is located in Minnesota.Explore more
Upsher-Smith Laboratories Org Chart
TT
Director, Operational Excellence
GD
Director, Materials Management & Supply Plann...
JT
Associate Director, Project Management
AT
Associate Director, Quality Control
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Upsher-Smith Laboratories your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Upsher-Smith Laboratories
Upsher-Smith Laboratories, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Upsher-Smith Laboratories launches new products
Website visits: Recent activity has been detected on your website
Check out if Upsher-Smith Laboratories is spiking on competitors!
Earning: See what the market has to say on Upsher-Smith Laboratories recently announced quarterly report
Click to see if Upsher-Smith Laboratories had a recent Job posting/layoffs
Check if Upsher-Smith Laboratories has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Upsher-Smith Laboratories has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Upsher-Smith Laboratories
Compare insights from companies similar to Upsher-Smith Laboratories, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Upsher-Smith Laboratories is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Upsher-Smith Laboratories is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Upsher-Smith Laboratories.
Upsher-Smith Laboratories Tech Stack
A closer look at the technologies used by Upsher-Smith Laboratories
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
Upsher-Smith Laboratories has more open roles in Legal than it has had at any time in the past 9 months.
Hiring Plans
Open Position
Open Position
Open Position
Upsher-Smith Laboratories News & Media
UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION
First Prescription Ear Drop Suspension Advances Portfolio Diversification Strategy MAPLE GROVE, Minn., April 6, 2026 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith), a subsidiary of Bora Pharmaceuticals Co., Ltd. (6472.TW and BORAY.OTCQX) today announced the recent launch of...UPSHER-SMITH LAUNCHES KYMBEE™ (DEFLAZACORT) TABLETS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
Company Reinforces Commitment to Rare Disease Community through its Promise of Support® Program MAPLE GROVE, Minn., Dec. 1, 2025 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of KYMBEE™ (deflazacort) Tablets, indicated for the treatment of...UPSHER-SMITH STRENGTHENS CONNECTIONS WITH THE EPILEPSY COMMUNITY THROUGH AWARENESS, EDUCATION, AND SUPPORT
From Epilepsy Awareness Day at Disneyland to the American Epilepsy Society Annual Meeting, the company continues its mission to improve understanding and care for people living with epilepsy and infantile spasms. MAPLE GROVE, Minn., Nov. 26, 2025 /PRNewswire/ -- Upsher-Smith Laboratories,...UPSHER-SMITH SHOWCASES ITS COMMITMENT TO DUCHENNE MUSCULAR DYSTROPHY COMMUNITY AS A TRUSTED PARTNER IN PEDIATRIC RARE DISEASES AT THE PARENT PROJECT MUSCULAR DYSTROPHY (PPMD) 2025 ANNUAL CONFERENCE
Visit Upsher-Smith at the PPMD 2025 Annual Conference Resource Fair to Learn More About Support Services and Resources Offered for Deflazacort Tablets MAPLE GROVE, Minn., June 16, 2025 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced its participation at the...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Upsher-Smith Laboratories
Sign Up For FreeTo access detailed company insights
Founded in 1919, Upsher-Smith Laboratories, LLC is an American pharmaceutical company that specializes in a wide variety of generics, as well as several brand medications that help patients living with seizure disorders and migraine headaches. Upsher-Smith Laboratories is located in Minnesota.... Read More
